Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Adeline Ayrolles-Torro"'
Autor:
Sara Cherradi, Véronique Garambois, Johanna Marines, Augusto Faria Andrade, Alexandra Fauvre, Olivia Morand, Manon Fargal, Ferial Mancouri, Adeline Ayrolles-Torro, Nadia Vezzo-Vié, Marta Jarlier, Gerald Loussaint, Steve Huvelle, Nicolas Joubert, Thibault Mazard, Céline Gongora, Philippe Pourquier, Florence Boissière-Michot, Maguy Del Rio
Publikováno v:
Cell & Bioscience, Vol 13, Iss 1, Pp 1-17 (2023)
Abstract Background Tumor resistance is a frequent cause of therapy failure and remains a major challenge for the long-term management of colorectal cancer (CRC). The aim of this study was to determine the implication of the tight junctional protein
Externí odkaz:
https://doaj.org/article/612613fc1c27490d8675f675e72b711a
Autor:
Vincent Denis, Christel Larbouret, Laetitia K. Linares, Esther Pérez-Gracia, Delphine Desigaud, Adeline Ayrolles-Torro, Nadia Vie, M. del Rio, Marta Jarlier, Clara Montagut, Diego Tosi, E W-F Lam, Laetitia Marzi, Mar Iglesias, Céline Gongora, Pierre Martineau, Eve Combes
Publikováno v:
British Journal of Cancer
British Journal of Cancer, Cancer Research UK, 2016, 115 (10), pp.1223-1233. ⟨10.1038/bjc.2016.313⟩
British Journal of Cancer, Cancer Research UK, 2016, 115 (10), pp.1223-1233. ⟨10.1038/bjc.2016.313⟩
BACKGROUND: Cetuximab, a monoclonal antibody against EGFR used for the treatment of colorectal cancer (CRC), is ineffective in many patients. The aim of this study was to identify the signalling pathways activated by cetuximab in CRC cells and define
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4579077d1c4aa1c4faf7dd0c8990a4d2
https://www.hal.inserm.fr/inserm-02465222
https://www.hal.inserm.fr/inserm-02465222
Autor:
Adeline Ayrolles-Torro, Maria Teresa Alvarez-Martinez, Joan Torrent, Alysson Duarte Rodrigues, Mike Robitzer, Jean-Michel Verdier, Véronique Perrier, Thibaut Imberdis, Gabor G. Kovacs
Publikováno v:
Molecular Neurodegeneration
Molecular Neurodegeneration, BioMed Central, 2016, 11 (1), pp.11. ⟨10.1186/s13024-016-0074-7⟩
Molecular Neurodegeneration, 2016, 11 (1), pp.11. ⟨10.1186/s13024-016-0074-7⟩
Molecular Neurodegeneration, BioMed Central, 2016, 11 (1), pp.11. ⟨10.1186/s13024-016-0074-7⟩
Molecular Neurodegeneration, 2016, 11 (1), pp.11. ⟨10.1186/s13024-016-0074-7⟩
Background Prion diseases are characterized by the accumulation in the central nervous system of an abnormally folded isoform of the prion protein, named PrPSc. Aggregation of PrPSc into oligomers and fibrils is critically involved in the pathogenesi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6b165a9a8ce42ac0f443e10f8d2ab6f
https://hal.umontpellier.fr/hal-02000137/file/document.pdf
https://hal.umontpellier.fr/hal-02000137/file/document.pdf
Autor:
Mike Robitzer, Gabor G. Kovacs, Jean-Michel Verdier, Véronique Perrier, Adeline Ayrolles-Torro, Thibaut Imberdis
Publikováno v:
Prion. 6:88-102
Autor:
Valérie Lobjois, Céline Gongora, Bernard Ducommun, Adeline Ayrolles-Torro, Sara Cherradi, Maguy Del Rio, Lucile Canterel-Thouennon, Eve Combes, Nadia Vezzo-Vié, Fabien Gava
Publikováno v:
Cancer Research. 78:2902-2902
Colorectal cancer (CRC) is one of the major causes of cancer-related deaths in the Western world. When localized, CRC is often curable by surgery, but the prognosis of patients with metastatic disease remains very poor. The current treatment of metas
Autor:
Vincent Denis, Céline Gongora, Christel Larbouret, Pierre Martineau, Nadia Vie, Eve Combes, Maguy Del Rio, Eric Lam, Clara Montagut, Laetitia K. Linares, Adeline Ayrolles-Torro, Mar Iglesias, Diego Tosi, Laetitia Marzi
Publikováno v:
Molecular Cancer Therapeutics. 14:B16-B16
Cetuximab is a monoclonal antibody against EGFR and is associated with 5-FU and irinotecan for the treatment of patients with colorectal cancer harboring wild type KRAS. However, cetuximab is ineffective in patients with constitutively active mutated
Autor:
Jean-Michel Verdier, G. Poncet-Montange, Ilia V. Baskakov, Thibaut Imberdis, Karine Toupet, Adeline Ayrolles-Torro, Catherine Grégoire, Véronique Perrier, Françoise Roquet-Baneres, Joan Torrent, Sylvain Lehmann, Martine Pugnière, Didier Rognan
Publikováno v:
Journal of Neuroscience
Journal of Neuroscience, Society for Neuroscience, 2011, 31 (42), pp.14882-14892. ⟨10.1523/JNEUROSCI.0547-11.2011⟩
Journal of Neuroscience, Society for Neuroscience, 2011, 31 (42), pp.14882-14892. ⟨10.1523/JNEUROSCI.0547-11.2011⟩
Accumulation of PrPSc, an abnormal form of cellular prion protein (PrP), in the brain of animals and humans leads to fatal neurodegenerative disorders known as prion diseases. Limited protease digestion of PrPScproduces a truncated form called PrP(27
Autor:
Nadia Vezzio-Vie, Vincent Denis, Imade Ait Arsa, Muriel Busson, Florence Boissière-Michot, Frédéric Bibeau, Martine Pugnière, Adeline Ayrolles-Torro, Pierre Martineau, Caroline Mollevi, Véronique Garambois, Céline Gongora, Maguy Del Rio
Publikováno v:
Molecular Cancer Therapeutics. 12:B245-B245
In metastatic colorectal cancer (CRC) patients, chemotherapy in combination with targeted therapies such as Avastin, Erbitux, and Vectibix (monoclonal antibodies) has improved response rates with prolongation of progression free survival and overall